These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15262303)

  • 21. Managing melanoma in situ.
    Toren KL; Parlette EC
    Semin Cutan Med Surg; 2010 Dec; 29(4):258-63. PubMed ID: 21277539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer.
    Lee JL; Kim A; Kopelovich L; Bickers DR; Athar M
    J Invest Dermatol; 2005 Oct; 125(4):818-25. PubMed ID: 16185283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
    McGillis ST; Fein H
    Semin Cutan Med Surg; 2004 Sep; 23(3):174-83. PubMed ID: 15584683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma.
    Sapijaszko MJ
    Skin Therapy Lett; 2005; 10(6):2-5. PubMed ID: 16292452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of viral infections and nonmelanoma skin cancers.
    Del Rosso JQ
    Cutis; 2007 Apr; 79(4 Suppl):29-35. PubMed ID: 17508493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS; Derksen E; Gaston K
    J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
    Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
    Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic deficiency or pharmacological inhibition of cyclooxygenase-1 or -2 induces mouse keratinocyte differentiation in vitro and in vivo.
    Akunda JK; Lao HC; Lee CA; Sessoms AR; Slade RM; Langenbach R
    FASEB J; 2004 Jan; 18(1):185-7. PubMed ID: 14630706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonmelanoma skin cancer of the head and neck: nonsurgical treatment.
    Ermertcan AT; Hellings PW; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):445-54. PubMed ID: 23084297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.
    Wilgus TA; Koki AT; Zweifel BS; Rubal PA; Oberyszyn TM
    Mol Carcinog; 2003 Sep; 38(1):33-9. PubMed ID: 12949841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: potentiation by Cox-2 inhibition.
    Merchan JR; Jayaram DR; Supko JG; He X; Bubley GJ; Sukhatme VP
    Int J Cancer; 2005 Jan; 113(3):490-8. PubMed ID: 15455390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):373-9. PubMed ID: 12769404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Network Meta-Analysis of Non-Melanoma Skin Cancer (NMSC) Treatments: Efficacy and Safety Assessment.
    Lv R; Sun Q
    J Cell Biochem; 2017 Nov; 118(11):3686-3695. PubMed ID: 28370183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [How I treat ... lentigo maligna by topical imiquimod].
    Bourguignon R; Paquet P; Quatresooz P; Piérard GE
    Rev Med Liege; 2005 Sep; 60(9):691-4. PubMed ID: 16265961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
    Dannenberg AJ; Altorki NK; Boyle JO; Dang C; Howe LR; Weksler BB; Subbaramaiah K
    Lancet Oncol; 2001 Sep; 2(9):544-51. PubMed ID: 11905709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of lentigo maligna with imiquimod 5% cream.
    Hopson B; Richey D; Sajben FP
    J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers].
    Eschwege P
    Bull Cancer; 2004 May; 91 Spec No():S113-6. PubMed ID: 15239339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical imiquimod: effectiveness in intraepithelial melanoma of oral mucosa.
    Spieth K; Kovács A; Wolter M; Bug R; Kaufmann R; Gille J
    Lancet Oncol; 2006 Dec; 7(12):1036-7. PubMed ID: 17138226
    [No Abstract]   [Full Text] [Related]  

  • 39. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunotherapy for nonmelanoma skin cancer: does it have a future?
    Urosevic M; Dummer R
    Cancer; 2002 Jan; 94(2):477-85. PubMed ID: 11900233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.